Curated clinical source
Stage II melanoma
A source-linked guide to questions families often ask around stage II melanoma.
- Clinical source
- Melanoma Treatment (PDQ) - Patient Version
- Publisher
- National Cancer Institute
- Reuse posture
- open-embed
- Last checked
- 2026-05-20
Stage II melanoma can still be localized, but risk discussions often become more detailed. The NCI PDQ melanoma summaries are the primary source for treatment category framing.
What to clarify
- What makes this stage II rather than stage I or stage III?
- Was sentinel lymph node biopsy done or discussed?
- Are additional scans or tests being considered?
- Is adjuvant therapy being discussed after surgery?
Questions to ask
- What is the goal after surgery: observation, adjuvant therapy discussion, trial search, or something else?
- What recurrence-risk factors matter most in this case?
- Should we ask a melanoma specialist for a second opinion before deciding on adjuvant treatment?